Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
59.77B | 59.38B | 57.79B | 54.30B | 46.88B | Gross Profit |
33.02B | 31.98B | 31.48B | 31.21B | 27.25B | EBIT |
14.68B | 13.97B | 14.52B | 13.82B | 7.80B | EBITDA |
19.35B | 19.13B | 18.91B | 17.39B | 11.22B | Net Income Common Stockholders |
5.86B | 5.34B | 5.97B | 4.67B | 148.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
11.39B | 10.40B | 10.00B | 12.39B | 15.56B | Total Assets |
206.64B | 219.34B | 212.94B | 217.63B | 226.41B | Total Debt |
72.17B | 78.17B | 79.99B | 88.83B | 98.56B | Net Debt |
60.99B | 67.84B | 70.09B | 76.81B | 83.40B | Total Liabilities |
117.94B | 126.66B | 128.66B | 138.29B | 148.06B | Stockholders Equity |
78.24B | 81.85B | 73.40B | 68.67B | 68.02B |
Cash Flow | Free Cash Flow | |||
11.19B | 8.63B | 8.14B | 9.16B | 9.18B | Operating Cash Flow |
15.05B | 13.27B | 13.30B | 14.80B | 14.04B | Investing Cash Flow |
-3.69B | -4.35B | -4.62B | -5.88B | -4.93B | Financing Cash Flow |
-9.42B | -8.60B | -10.62B | -11.60B | -8.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $122.96B | 20.78 | 7.48% | 1.06% | 0.64% | 9.21% | |
74 Outperform | $12.07B | 11.14 | 8.57% | 2.92% | -0.64% | 22.45% | |
73 Outperform | $48.95B | 45.48 | 4.99% | 1.72% | -1.73% | -57.46% | |
73 Outperform | $15.43B | 15.43 | 27.10% | 2.66% | -4.34% | 30.36% | |
69 Neutral | $2.69B | 48.47 | 6.52% | ― | 0.21% | -20.69% | |
63 Neutral | $20.85B | 13.27 | -10.88% | 7.48% | 1.13% | 11.50% | |
61 Neutral | $31.68B | 46.93 | 8.78% | 2.30% | 3.69% | -55.78% |